Skip to main content

US ClosedU.S. Closed

BLRX: BioLineRx Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

BioLineRx Ltd. , an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology.

52W Range

15thpctl

Volume

0.24×avg

Market Cap

10.92MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

BioLineRx Ltd.

BLRXNASDAQ Capital Market·USD·Closed

BioLineRx Ltd.

BLRXNASDAQ·USD·Closed

$2.51

−2.32%

$2.51

−$0.06 (2.32%)

52W Range

15thpctl

Volume

0.24×avg

Mkt Cap

10.92MUSD

P/E

-1.4TTM

Div Yield

–ann